Belite Bio, Inc (BLTE) stock
BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
$169.96+14.02 (+8.99%)
Close on Nov 12, 2026Market cap $6.69BP/E –Yield –
Belite Bio ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Belite Bio
Belite Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?